Spread, Not Shed
A CoreWeave co-founder told the Financial Times this week where the next round of AI-chip financing could come from. Brannin McBee, who leads CoreWeave's financing, said that winning investment-grade ratings for more of its chip-backed debt would let it borrow from insurers, whose capital "is unlimited". The FT's insurance correspondent had already supplied the other half, saying many large traditional insurers are at their limit for exposure to AI companies. Both can be true at once. Insurance money is already in this market, in investment-grade paper and below it, and the filings name the insurers: 58 purchasers of IREN's notes, more than half of them US life and annuity insurers, and insurers among the lenders on CoreWeave's GPU facilities. Where they are named, the amounts are redacted or not given. What is new is the scale being discussed and the ratings it would take. For scale, the NAIC estimates US insurers' exposure to all private credit at $1.2 trillion at the end of 2025, about 13% of cash and invested assets. It does not break out data centers or AI, and no official figure does.










